Kenjockety Biotechnology, Inc.
About Kenjockety Biotechnology, Inc.
The startup develops bispecific antibodies (BsAbs) that target efflux pumps and tumor-associated antigens (TAAs) to enhance the specificity of cancer treatments. This approach aims to improve therapeutic efficacy for patients facing drug-resistant tumors by selectively targeting cancer cells while sparing normal cells.
What does Kenjockety Biotechnology, Inc. do?
The startup develops bispecific antibodies (BsAbs) that target efflux pumps and tumor-associated antigens (TAAs) to enhance the specificity of cancer treatments. This approach aims to improve therapeutic efficacy for patients facing drug-resistant tumors by selectively targeting cancer cells while sparing normal cells.
Where is Kenjockety Biotechnology, Inc. located?
Kenjockety Biotechnology, Inc. is based in Tiburon, United States.
How much funding has Kenjockety Biotechnology, Inc. raised?
Kenjockety Biotechnology, Inc. has raised 4000000.
- Location
- Tiburon, United States
- Funding
- 4000000
- Employees
- 3 employees